IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crispr Therapeutics AG

CUSIP: 033408113 | 3 institutional holders

Quarters

Q3 2023Q2 2023Q1 2023Q4 2021Q4 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2023

Value Star Asset Management (Hong Kong) Ltd17,650
0.3% of portfolio›$801.1K
StyleTurnoverLocationFiled
Value Star Asset Management (Hong Kong) Ltd
17,650$801.1K0.3%Agg GrowthMediumHong Kong, South Korea2023-11-08